Lipidologists offer specialized insight into the management of dyslipidemias, particularly in endocrine patients where abnormal lipid profiles often coexist with metabolic and hormonal imbalances. Their expertise goes beyond standard lipid panels, extending to the evaluation of non-HDL cholesterol, apolipoprotein ratios, and residual cardiovascular risk in diabetic populations. In the context of endocrinology, lipidologists help decipher how insulin resistance, thyroid dysfunction, and adrenal hormones influence lipid metabolism and systemic inflammation.
These specialists also contribute to individualized treatment pathways by incorporating genetic data, imaging for subclinical atherosclerosis, and emerging therapies like PCSK9 inhibitors and lipid-modifying RNA agents. Through a personalized lens, lipidologists assess familial hypercholesterolemia, mixed dyslipidemia, and hypertriglyceridemia in patients whose endocrine disorders further complicate lipid regulation. Their role is central in preventing atherosclerotic events, optimizing long-term vascular health, and informing clinical decisions on when to escalate therapy. By integrating cardiovascular risk stratification into endocrine care, lipidologists help align metabolic stability with improved survival outcomes.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences